193 related articles for article (PubMed ID: 12193564)
1. Functional maturation of fetal porcine beta-cells by glucagon-like peptide 1 and cholecystokinin.
Hardikar AA; Wang XY; Williams LJ; Kwok J; Wong R; Yao M; Tuch BE
Endocrinology; 2002 Sep; 143(9):3505-14. PubMed ID: 12193564
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
[TBL] [Abstract][Full Text] [Related]
3. Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1.
Otonkoski T; Hayek A
J Clin Endocrinol Metab; 1995 Dec; 80(12):3779-83. PubMed ID: 8530635
[TBL] [Abstract][Full Text] [Related]
4. Exendin 4 up-regulates expression of PDX 1 and hastens differentiation and maturation of human fetal pancreatic cells.
Movassat J; Beattie GM; Lopez AD; Hayek A
J Clin Endocrinol Metab; 2002 Oct; 87(10):4775-81. PubMed ID: 12364473
[TBL] [Abstract][Full Text] [Related]
5. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.
van der Burg MP; Guicherit OR; Frölich M; Gooszen HG
Regul Pept; 1995 Dec; 60(1):61-7. PubMed ID: 8747785
[TBL] [Abstract][Full Text] [Related]
6. Effect of stimulators such as GLP-1, PACAP, and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in long-term culture.
Sato A; Wang PC; Ohgawara H
Pancreas; 2002 Jul; 25(1):86-93. PubMed ID: 12131777
[TBL] [Abstract][Full Text] [Related]
7. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.
Sjöholm A; Sandberg E; Ostenson CG; Efendić S
Pancreas; 2000 Apr; 20(3):282-9. PubMed ID: 10766455
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
Perfetti R; Zhou J; Doyle ME; Egan JM
Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
[TBL] [Abstract][Full Text] [Related]
9. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
Abraham EJ; Leech CA; Lin JC; Zulewski H; Habener JF
Endocrinology; 2002 Aug; 143(8):3152-61. PubMed ID: 12130581
[TBL] [Abstract][Full Text] [Related]
10. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
[TBL] [Abstract][Full Text] [Related]
11. GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.
Egan JM; Bulotta A; Hui H; Perfetti R
Diabetes Metab Res Rev; 2003; 19(2):115-23. PubMed ID: 12673779
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
Drucker DJ
Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
[TBL] [Abstract][Full Text] [Related]
13. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
García-Flores M; Zueco JA; Alvarez E; Blázquez E
Eur J Biochem; 2001 Feb; 268(3):514-20. PubMed ID: 11168389
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 does not mediate amylase release from AR42J cells.
Zhou J; Montrose-Rafizadeh C; Janczewski AM; Pineyro MA; Sollott SJ; Wang Y; Egan JM
J Cell Physiol; 1999 Dec; 181(3):470-8. PubMed ID: 10528233
[TBL] [Abstract][Full Text] [Related]
15. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.
Fehmann HC; Hering BJ; Wolf MJ; Brandhorst H; Brandhorst D; Bretzel RG; Federlin K; Göke B
Pancreas; 1995 Aug; 11(2):196-200. PubMed ID: 7479679
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells.
Zhou J; Wang X; Pineyro MA; Egan JM
Diabetes; 1999 Dec; 48(12):2358-66. PubMed ID: 10580424
[TBL] [Abstract][Full Text] [Related]
17. Influence of glucagon-like peptide-1 on beta cell responsiveness.
Zawalich WS; Zawalich KC; Rasmussen H
Regul Pept; 1993 Apr; 44(3):277-83. PubMed ID: 8484020
[TBL] [Abstract][Full Text] [Related]
18. Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.
Salehi A; Ekelund M; Lundquist I
Horm Metab Res; 2003 Jan; 35(1):48-54. PubMed ID: 12669271
[TBL] [Abstract][Full Text] [Related]
19. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides.
Rehfeld JF
Acta Physiol (Oxf); 2011 Apr; 201(4):405-11. PubMed ID: 21392266
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
Zawalich WS; Zawalich KC
Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
